Caption

A radiotracer (that binds to a marker of inflammation) shows elevation of the chemical marker in the brain scans of 12 participants with post-treatment Lyme disease syndrome, compared to 19 healthy control participants. Courtesy of Coughlin et al., Journal of Neuroinflammation, 2018